Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.

Zhang, Jiaxin; Wang, Siyuan; Zhang, Daidi; He, Xin; Wang, Xue; Han, Huiqiong; Qin, Yanru

Zhang, Jiaxin; Wang, Siyuan; Zhang, Daidi; He, Xin; Wang, Xue; Han, Huiqiong; Qin, Yanru.

Afiliação

Zhang J; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang S; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhang D; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
He X; Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang X; Academy of Medical Science, School of Basic Medical Science, Zhengzhou University, Zhengzhou, China.
Han H; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qin Y; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Front Immunol ; 14: 1230893, 2023.

Article em En | MEDLINE | ID: mdl-37600822

Assuntos

Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos; Nanopartículas; Neoplasias; Humanos; Sistemas de Liberação de Fármacos por Nanopartículas; Imunoterapia; Neoplasias/terapia

Palavras-chave

EPR effect; immunogenic cell death; immunotherapy; nanodrug delivery systems; nanoparticles; solid tumors; tumor microenvironment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google